Funded Tech Companies
Cyteir Therapeutics
Wondering who invested in Cyteir Therapeutics? Ally Bridge Group, Ample Plus Fund and Novo Ventures put venture money into this biopharmaceutical company.
Company Overview
Company Name
Cyteir Therapeutics
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
128 Spring St. Building A 510
Lexington, MA 02421
USA
Lexington, MA 02421
USA
Phone
Website
Email Address
Company Background Information
Overview
DNA damage and genomic instability are hallmarks of cancer and autoimmune diseases. This makes the disease-causing cells highly sensitive to drugs that target specific DNA repair factors. This is termed synthetic lethality.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
6/18/2021
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Markus Renschler
Chief Scientific Officer
Paul Secrist
Vice President
Jean-Marc Lapierre
Vice President
Thomas O'Shea
VP - Bus. Development
Andrew Gengos
VP - Operations
Susan Doleman
VP - R & D
Judson Englert
VP - R & D
Barbara Wan
Company Investors
- Ally Bridge Group
- Ample Plus Fund
- Novo Ventures
- Avidity Partners
- Venrock (Racquel Bracken)
- Osage Partners
- DROIA (Bart Hooland)
- CaaS Capital Management
- RA Capital (Derek DiRocco)
- Lightstone Ventures (Jean George)
- Acuta Capital
- Janus Henderson Investors
- Celgene (Markus Renschler)
Browse more funded tech companies:
Share this article
About Our VC Transaction Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs